Skip to main content

Table 4 Mean and standard deviation of metabolites level in ACLF (baseline) compared to controls and follow−up

From: Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology

Groups Metabolites (mmol/kg)
NAA MI Glx
Control (a) 12.9 ± 1.30 2.60 ± 0.50 15.0 ± 2.50
Baseline (b) 10.9 ± 1.15 1.40 ± 0.69 22.5 ± 5.41
Follow−up (c) 11.2 ± 1.00 1.72 ± 0.41 18.1 ± 3.62
p-values
 a vs b a − b = 0.001 a −b = 0.001 a − b = 0.001
 a vs c a − c = 0.004 a − c = 0.001 a − c = 0.030
 b vs c b − c = 0.424 b − c = 0.184 b − c = 0.024
  1. NAA N-acetyl aspartate, mI myo inositol, Glx glutamine/glutamate